Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions

Documenti analoghi

• Commentary on Gregory et al .: Fear of precipitated opioid withdrawal should not prevent buprenorphine initiation
  di: Sandra A. Springer
  Pubblicazione: (2024)
• A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine
  di: Charles Deng, et al.
  Pubblicazione: (2025)
• Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review
  di: Emmert Roberts, et al.
  Pubblicazione: (2026)
• Evaluating the optimal duration of medication treatment for opioid use disorder
  di: Corey J. Hayes, et al.
  Pubblicazione: (2026)
• Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA
  di: Gary J. Young, et al.
  Pubblicazione: (2024)